cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection
RxNorm concept 1942743, clinical drug (scd). Prescribable name: cytarabine 100 MG / DAUNOrubicin 44 MG Liposome Injection.
- RxCUI
- 1942743
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1942743 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
ara-C liposome 100 MG / DAUNOrubicin Liposomal 44 MG Injection; ara-C liposome 100 MG / Daunorubicin Liposomal 44 MG Injection; cytarabine 100 MG / DAUNOrubicin 44 MG Liposome Injection; cytarabine 100 MG / daunorubicin 44 MG Liposome Injection; cytarabine liposome 100 MG / DAUNOrubicin liposomal 44 MG Injection
Related concepts
- cytarabine liposome 100 MG (SCDC, consists of)
- daunorubicin liposomal 44 MG (SCDC, consists of)
- Injection (DF, has dose form)
- cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection [Vyxeos] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1942743 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1942743 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1942743. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.